Loading...

Kay-Won Chang

TitleResident Physician
InstitutionUniversity of California San Diego
DepartmentMedicine
Address200 W. Arbor Drive #8425
San Diego CA 92103
Phone619-543-6268
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Chang K, Beri N, Nguyen NH, Arbit B, Fox S, Mojaver S, Clopton P, Tam SW, Taylor AL, Cohn JN, Maisel AS, Anand IS. Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial. J Card Fail. 2017 Sep 13. PMID: 28918108.
      View in: PubMed
    2. Chang K, Fox S, Mojaver S, Maisel AS. Using biomarkers to guide heart failure management. Expert Rev Cardiovasc Ther. 2017 Oct; 15(10):729-741. PMID: 28830266.
      View in: PubMed
    3. Chang K, Hsu JC, Toomu A, Fox S, Maisel AS. Clinical Applications of Biomarkers in Atrial Fibrillation. Am J Med. 2017 Dec; 130(12):1351-1357. PMID: 28822701.
      View in: PubMed
    4. Chang K, Arbit B, Hsu JC. Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review. Int J Cardiol. 2017 Sep 15; 243:263-269. PMID: 28595745.
      View in: PubMed
    5. Solhpour A, Chang K, Arain SA, Balan P, Zhao Y, Loghin C, McCarthy JJ, Vernon Anderson H, Smalling RW. Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2016 Nov; 88(5):709-715. PMID: 27028120.
      View in: PubMed
    6. Solhpour A, Chang K, Balan P, Cai C, Sdringola S, Denktas AE, Smalling RW, Anderson HV. Comparison of outcomes for patients =75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Am J Cardiol. 2014 Jan 01; 113(1):60-3. PMID: 24207074.
      View in: PubMed
    Kay-Won's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _